Cardocal Tablet 5 mg is a calcium channel blocker used primarily in the treatment of hypertension (high blood pressure). It is a dihydropyridine derivative with specific properties that make it effective in managing blood pressure levels.
Cardocal Tablet 5 mg is used for:
| Brand Name | Cardocal |
|---|---|
| Type | Tablet |
| Weight | 5 mg |
| Generic | Cilnidipine |
| Manufacturer | Beximco Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Cardocal Tablet 5 mg works by inhibiting the influx of calcium ions through L-type calcium channels in the vascular smooth muscle and cardiac tissue. This leads to relaxation of blood vessels, resulting in decreased peripheral resistance and lowered blood pressure.
Clinical effects of Cardocal Tablet 5 mg can typically be observed within 1-2 hours of administration, with peak antihypertensive effects occurring within 4-6 hours. Full therapeutic effects are often seen after a few weeks of consistent use.
Cardocal Tablet 5 mg is well absorbed from the gastrointestinal tract. Its bioavailability may be affected by food, with absorption potentially being reduced when taken with high-fat meals.
Cardocal Tablet 5 mg is metabolized primarily in the liver. It is excreted through the urine and bile, with a small portion eliminated unchanged in the urine.
The typical dosage of Cardocal Tablet 5 mg for hypertension is:
Cardocal Tablet 5 mg is administered orally. It is typically taken once daily, with or without food. The tablets should be swallowed whole with a glass of water.
Common side effects of Cardocal Tablet 5 mg may include:
Less common but serious side effects may include:
Overdose of Cardocal Tablet 5 mg can result in severe hypotension, leading to symptoms such as dizziness, fainting, and rapid heart rate. In case of overdose, immediate medical attention is required to manage symptoms and provide supportive care.
Precautions to consider include:
Cardocal Tablet 5 mg may interact with other medications, potentially altering its efficacy or increasing the risk of side effects. Common interactions include:
Use Cardocal Tablet 5 mg with caution in patients with:
Drug interactions to be aware of include:
Food may affect the absorption of Cardocal Tablet 5 mg. It is generally advised to avoid high-fat meals around the time of taking the medication to prevent reduced absorption.
The safety of Cardocal Tablet 5 mg during pregnancy has not been well-established. It should only be used if the potential benefits outweigh the risks, and under the guidance of a healthcare provider.
It is not known whether Cardocal Tablet 5 mg is excreted in breast milk. Caution is advised when using this medication during lactation, and consultation with a healthcare provider is recommended.
In case of acute overdose, seek immediate medical attention. Treatment may include supportive measures and symptomatic management to address hypotension and other effects.
Cardocal Tablet 5 mg is contraindicated in individuals with:
Follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not alter the dose or frequency without medical advice.
Store Cardocal Tablet 5 mg tablets in a cool, dry place, away from direct sunlight. Keep them out of reach of children and ensure the container is tightly closed.
The volume of distribution of Cardocal Tablet 5 mg is approximately 1.6 L/kg, indicating it is widely distributed throughout the body.
The elimination half-life of Cardocal Tablet 5 mg is approximately 4 to 6 hours. This allows for once-daily dosing in most patients.
Cardocal Tablet 5 mg is primarily cleared through hepatic metabolism and biliary excretion. Its clearance can be affected by liver function and concurrent use of other medications.
See in details version Cardocal Tablet 5 mg also Cardocal Tablet 5 mg in bangla
Dr. Chowdhury Iqbal Mahmud
Trauma, Knee, Arthroscopic, Bone, Joint, Injury & Fractures Surgeon